ERIS Lifesciences Ltd 07 Feb 2025 12:00 AM
Board of ERIS Lifesciences recommends Interim Dividend,
ERIS Lifesciences announced that the Board of Directors of the Company at its meeting held on 06 February 2025, has recommended a Interim dividend of Rs.7.35 per share (i.e.735%), subject to the approval of the shareholders.Powered by Capital Market - Live News
ERIS Lifesciences Ltd 05 Feb 2025 12:00 AM
ERIS Lifesciences schedules board meeting,
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live News
ERIS Lifesciences Ltd 04 Feb 2025 12:00 AM
ERIS Lifesciences consolidated net profit declines 18.60% in the December 2024 quarter,
Net profit of ERIS Lifesciences declined 18.60% to Rs 83.63 crore in the quarter ended December 2024 as against Rs 102.74 crore during the previous quarter ended December 2023. Sales rose 49.36% to Rs 722.12 crore in the quarter ended December 2024 as against Rs 483.48 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales722.12483.48 49 OPM %34.6636.30 - PBDT197.36161.59 22 PBT116.16115.87 0 NP83.63102.74 -19 Powered by Capital Market - Live News
ERIS Lifesciences Ltd 29 Jan 2025 12:00 AM
ERIS Lifesciences to hold board meeting,
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live News
ERIS Lifesciences Ltd 25 Oct 2024 12:00 AM
Board of Eris Lifesciences approves acquisition of 30% stake in Levim Lifetech,
The Board of Eris Lifesciences at its meeting held on 25 October 2024 has approved the execution of Binding Term Sheet with Levim Lifetech and its shareholders for the purpose of acquiring 30% stake in Levim Lifetech for an investment of Rs 54 crore at a pre-money equity valuation of Rs 126 crore. The acquisition is aimed at expansion of the company`s biotechnology footprint across a wide range of products and technologies. Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now